Katherine Ruzhansky

Concepts (61)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Amyloid Neuropathies, Familial
2
2017
21
0.640
 Why?
Neuromuscular Diseases
1
2015
14
0.540
 Why?
Myasthenia Gravis
3
2021
17
0.530
 Why?
Threonine
1
2014
47
0.500
 Why?
Prealbumin
1
2014
25
0.500
 Why?
Twins, Monozygotic
1
2014
27
0.500
 Why?
Lysine
1
2014
96
0.490
 Why?
Graft vs Host Disease
1
2015
163
0.450
 Why?
Hematopoietic Stem Cell Transplantation
1
2015
245
0.450
 Why?
Physicians
3
2022
324
0.420
 Why?
Receptors, Cholinergic
2
2019
30
0.330
 Why?
Receptor Protein-Tyrosine Kinases
2
2019
100
0.310
 Why?
Postoperative Complications
1
2015
1615
0.310
 Why?
Drugs, Investigational
1
2022
18
0.210
 Why?
Adverse Drug Reaction Reporting Systems
1
2022
41
0.210
 Why?
Nervous System Diseases
1
2022
142
0.190
 Why?
Patient Reported Outcome Measures
1
2022
114
0.190
 Why?
Rituximab
2
2019
61
0.190
 Why?
Physical Examination
1
2021
152
0.190
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2022
148
0.190
 Why?
Thymectomy
1
2019
11
0.170
 Why?
Patient Education as Topic
1
2021
424
0.160
 Why?
Neurologists
1
2017
15
0.150
 Why?
Diagnostic Techniques, Neurological
1
2017
6
0.150
 Why?
Oligonucleotides
1
2017
34
0.150
 Why?
Immunologic Factors
1
2017
87
0.150
 Why?
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
2015
3
0.140
 Why?
Neuromuscular Junction Diseases
1
2015
1
0.140
 Why?
Paraproteinemias
1
2015
4
0.140
 Why?
4-Aminopyridine
1
2015
5
0.140
 Why?
Orphan Drug Production
1
2015
3
0.140
 Why?
Potassium Channel Blockers
1
2015
32
0.140
 Why?
Peripheral Nervous System Diseases
1
2015
37
0.140
 Why?
Autoantibodies
1
2017
434
0.130
 Why?
Severity of Illness Index
2
2017
1851
0.130
 Why?
Telemedicine
1
2021
699
0.110
 Why?
Phenotype
1
2014
946
0.100
 Why?
Middle Aged
6
2022
21119
0.090
 Why?
Humans
9
2022
68525
0.080
 Why?
Female
7
2022
38015
0.080
 Why?
Prednisone
2
2019
104
0.080
 Why?
Adult
5
2022
21375
0.060
 Why?
Male
6
2022
37281
0.050
 Why?
Cohort Studies
2
2019
2356
0.050
 Why?
Immunoglobulins, Intravenous
1
2019
52
0.040
 Why?
Age of Onset
1
2019
188
0.040
 Why?
Neural Conduction
1
2017
24
0.040
 Why?
Aged
3
2019
14842
0.040
 Why?
International Cooperation
1
2017
88
0.040
 Why?
Aged, 80 and over
2
2017
4843
0.040
 Why?
Single-Blind Method
1
2017
249
0.040
 Why?
Treatment Outcome
2
2019
7028
0.030
 Why?
Young Adult
2
2019
5708
0.030
 Why?
Anti-Inflammatory Agents
1
2017
234
0.030
 Why?
Disability Evaluation
1
2017
298
0.030
 Why?
Retrospective Studies
2
2019
7264
0.030
 Why?
Surveys and Questionnaires
1
2022
2798
0.030
 Why?
Follow-Up Studies
1
2017
3256
0.020
 Why?
Prospective Studies
1
2017
3702
0.020
 Why?
Child
1
2019
6400
0.020
 Why?
Adolescent
1
2019
8903
0.020
 Why?
Ruzhansky's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (61)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_